MENU
BPMUF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Basilea Pharmaceutica AG (BPMUF) Ownership - Who owns Basilea Pharmaceutica AG?
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections... Show more
Profile
Industry
N/A
Address
Hegenheimermattweg 167b
Phone
+41 616061111
Employees
147
Web
https://www.basilea.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
720.52M
P/E Ratio
9.96
Total Cash
62.96M
Projected Growth
N/A
Total Debt
112.45M
Revenue
149.02M
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash/Share
5.13
Total Debt/Equity
N/A
Revenue/Share
21.15 USD as % of share price
Fundamentals
BPMUF
Capitalization
721M
P/E Ratio
9.96
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash
63M
Total Cash/Share
5.13
Total Debt
112M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
21.15%
Revenue
149M
ROE
N/A
Book Value
16.8M
P/B Ratio
6.49
Cash Flow
N/A
Earnings
-0.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13.2M
Current Ratio
4.10
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-4.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-0.31
Shares Held By Institutions
186M
Shares Outstanding - Current
12.3M
Total Liabilities
172M
Total Volume MTD
N/A
Value
-1
Gain YTD
28.242
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Hegenheimermattweg 167b
Phone
+41 616061111
Employees
147
Web
https://www.basilea.com